Sign in
4

Changes in Ownership

Estrella Immunopharma, Inc. Filed Acc 0001996255-26-000004

CEO acquired 100,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Liu Cheng · CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-08-25 Exercise or conversion : show line 1 in the form +100,000 $0.82 $81,500 397,437 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-08-25 Exercise or conversion : show line 2 in the form Incentive Stock Option +100,000 900,000 D
Loading xslF345X06/primary_doc.xml…